SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Avenue Therapeutics Q1 EPS $(0.080) Up From $(0.820) YoY

Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(0.080) per share. This is a 90.24 percent increase over losses of $(0.820) per share from the same period last year.

Benzinga · 05/11/2020 11:33

Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(0.080) per share. This is a 90.24 percent increase over losses of $(0.820) per share from the same period last year.